1. Seelig MS. Magnesium Deficiency in the Pathogenesis of Disease. Early Roots of Cardiovascular, Skeletal, and Renal Abnormalities. Plenum Publ Corp, NY, 1980.
2. Lazard EM. A preliminary report on the intravenous use of magnesium sulphate in puerperal eclampsia. Am J Obst Gynec 1925;26:647-656.
3. Pritchard JA. The use of magnesium in the management of eclamptic toxemias. Surg Obst Gynec 1955;100:131-140.
4. Boyd LJ, Scherf D. Magnesium sulfate in paroxysmal tachycardia. Am J Med Sc 1943;206:43-48.
5. Szekely P. The action of magnesium on the heart. Brit Heart J 1946; 8:115-124.
6. Iseri LT, Freed J, Bures AR. Magnesium deficiency and cardiac disorders. Am J Med 1975;58:837-846.
7. Chadda KD, Lichstein E, Gupta P. Hypomagnesemia and Refractory arrhythmia in a nondigitalized patient. Am J Cardiol 1973;31:98-100.
8. Iseri LT. Magnesium and Dysrhythmias. Magn Bull 8: 223-229, 1986.
9. Packer M, Gottlieb SS, Kessler PD. Hormone-electrolyte interactions in the pathogenesis of lethal cardiac arrhythmias in patients with congestive heart failure, basis of a new physiologic approach to control of arrhythmia. Am J Med 1986;80 (Suppl 4A):23-29.
10. Wacker WEC. "Magnesium and Man", Harvard University Press, Cambridge, MA 1980.
11. Aikawa JK. "Magnesium: Its Biologic Significance", CRC Press, Boca Raton, FL, 1981
12. Green DE, Fleischer S. The mitochondrial system of enzymes. in "Metabolic Pathways", Academic Press, 1980
13. Seelig MS, Heggtveit HA. Magnesium interrelationships in ischemic heart disease. Am J Clin Nutr 1974;27:59-79.
14. Lehr D. Tissue electrolyte alteration in disseminated myocardial necrosis. Ann NY Acad Sci 1969;156:344-378.
15. Schroeder HA. Relations between mortality from cardiovascular disease and treated water supplies. JAMA 1960:172:1902-1908.
16. Karppanen H, Neuvoenen PJ. Ischemic heart disease and soil magnesium in Finland (letter). Lancet 1973;2.1390.
17. Marier JR. Role of magnesium in the "hard water story". Magnesium Bull 1986;8:194-198.
18. Anderson T, Neri LC, Schreiber GB, Talbot F, Zdrowjewski A. Ischemic heart disease, water hardness, and myocardial magnesium. Can Med Assoc J 1975;113:199-203.
19. Anderson TW, LeRiche WH: Sudden death from ischemic heart disease in Ontario and its correlation with water hardness and other factors. Can Med Assoc J 1971;105:155-160.
20. Altura BM, Altura BT, Carella A, Prasad DMV. Hypomagnesemia and vasoconstriction: possible relationship to etiology of sudden death ischemic disease and hypertensive vascular disease. Artery 1981;9:212-213.
21. Whang R, Flink EB, Dyckner T, Wester PO, Aikawa JK, Ryan MP. Magnesium depletion as a cause of refractory potassium repletion. Arch Intern Med 1985;145:1686-1689.
22. Ryan MP: Diuretics and potassium/magnesium depletion. Directions for treatment. Am J Med 1987;82(Suppl 3A):38-47.
23. Dyckner T, Wester PO. Potassium/magnesium depletion in patients with cardiovascular disease. Am J Med 1087;82(Suppl 3A):11-17.
24. Cohen JJ, Kassirer JP. Acid base metabolism. In Maxwell MH, Kleeman CR, eds. Clinical Disorders of Fluid and Electrolyte Metabolism. New York:McGraw-Hill Book Co, 1980:1812-232.
25. Field MJ, Lawrence JR. Complications of thiazide therapy: an update. Med J Aust 1986;144:641-644.
26. Seelig MS: The requirement of magnesium by the normal adult. Am J Clin Nutr 1964;14:342-390.
27. Seelig MS: Magnesium requirements in human nutrition. Magnesium Bull 1981;3 (Suppl 1A):26-47.
28. Committee on Dietary Allowance: Recommended dietary allowances. Magnesium. 9th Revised Edition. National Academy of Sciences, Washington, D.C., 1980, pp 134-136.
29. USDA. Food and nutrient intakes of individuals on 1 day in the U.S., Spring 1977. Nationwide Food Consumption Survey 1977-1978. Preliminary Report #2, Washington DC, 1980.
30. Morgan KJ, Stampley GL, Zabik ME, Fischer DR. Magnesium and calcium intakes of the U.S. population. J Am Coll Nutr 1985;4: 195-206.
31. Lakshmanan FL, Rao RB, Kim WW, Kelsay JL. Magnesium intakes, balances, and blood levels of adults consuming self-selected diets. Am J Clin Nutr 1984;40:1380-1389.
32. Walker M, Page L. Nutritive content of college meals. III. Mineral elements. J Am Diet Assoc 1977;70:260-266.
33. Srivastava US, Nadeau MJ, Guennou L. Nutrition Reports Intl 1978;18:235-242.
34. White HS. Inorganic elements in weighed diets of girls and young women. J Am Diet Assoc 1969;55:38-43.
35. Seelig MS, Haddy FJ. Magnesium and the arteries. I. Effects of magnesium deficiency on arteries and on the retention of sodium, potassium and calcium. in Cantin M, Seelig MS, eds. Magnesium in Health and Disease. New York: SP Med & Sc Books, 1980:605-638.
36. Rayssiguier Y. Magnesium and lipid interrelationships in the pathogenesis of vascular diseases. Magnesium Bull 1981;3:165-177.
37. Rayssiguier Y. Lipoprotein metabolism: importance of magnesium. Magnesium Bull 1986;8:186-193.
38. Rayssiguier Y, Gueux E. Magnesium and lipids in cardiovascular disease. J Am Coll Nutr 1986;5:507-519.
39. Vitale JJ, White PL, Nakamura M, Zamcheck N, Hellerstein EE. Interrelationships between experimental hypercholesterolemia, magnesium requirements, and experimental atherosclerosis. J Exp Med 1957;106:757-766.
40. Hellerstein E, Vitale JJ,White PL, Hegsted D, Zamcheck N, Nakamura M. Influence of dietary magnesium on cardiac and renal lesions of young rats Fed an atherogenic diet. J Exp Med 1957: 106:767-775.
41. Vitale JJ, Velez H, Guzman C, Correa P. Magnesium deficiency in the cebus monkey. Circ Res 1963;12:642-650.
42. Elin RJ: Magnesium Metabolism in Health and Disease. Disease-a- Month 34: 161-218, 1988.
43. Szelenyi Y, Rigo R, Ahmen BO, Sos J. The role of magnesium in blood coagulation. Thromb Diath Haemaorrh 1967;18:626-633.
44. Rayssiguier Y, Gueux E, Weiser D. Effect of magnesium deficiency on lipid metabolism in rats fed a high carbohydrate diet. J Nutr 1981;111:1876-1883.
45. Rayssiguier Y, Gueux E. The reduction of plasma triglyceride clearance by magnesium-deficient rats. Magnesium 1983;2:132-138.
46. Kruse H, Orent E, McCollum E. Studies on magnesium deficiency in animals. III. Chemical Changes in the blood following magnesium deprivation. J Biol Chem 1933;100:603-643.
47. Gueux E, Rayssiguier Y, Piot M-C, Alcindor L: Reduction of plasma lecithin-cholesterol acyl-transferase activity by acute magnesium deficiency in the rat. J Nutr 1984;114:1479-1483.
48. Davis WH, Leary WP, Reyes AJ, Ohlaberry JV: Monotherapy with magnesium increases abnormally low high density lipoprotein cholesterol: a clinical assay. Curr Ther Res 36;1984:341-344.
49. Lindeman RD, Adler S, Yiengst MJ, Beard ES. Influence of various nutrients on urinary divalent cation excretion. L Lab Clin Med 1967;70:236-245.
50. Martin HE.: Clinical magnesium deficiency. Ann NY Acad Sci 1969;156:891-900.
51. Martin HE, Wertman M. Serum potassium, magnesium and calcium levels in diabetic acidosis. J Clin Invest 1947;26:217-228.
52. Ditzel J. Morphologic and hemodynamic changes in the smaller blood vessels in diabetes mellitus. I. Considerations based on the literature. New Engl J Med 1954;250:551-546.
53. James TN. Pathology of small coronary arteries. Am J Cardiol 1967;20:679-691.
54. Linden V. Correlation of vitamin D intake to ischemic heart disease, hypercholesterolemia, and renal calcinosis. In Seelig MS ed. Nutritional Imbalances in Infant and Adult Disease: Mineral, Vitamin D and Cholesterol. New York, Spectrum Pub 1977: 23-42.
55. Linden V, Seelig MS. Multiple factors in the hyperlipidemia of hypervitaminosis D (letter). Br Med J 1975;4:166.
56. Harris LJ. The mode of action of vitamin D. The "parathyroid" theory: clinical hypervitaminosis. Lancet 1932;1:1031-1038.
57. Forfar JO, Tompsett SL, Forshall W. Biochemical studies in idiopathic hypercalcemia in infancy. Arch Dis Childh 1959;34: 525-537.
58. Seelig MS. Vitamin D and cardiovascular, renal, and brain damage in infancy and childhood. An NY Acad Sci 1969;147: 537-582.
59. Seelig MS. Magnesium deficiency with phosphate and vitamin D excesses: role in pediatric cardiovascular disease? Cardiovasc Med 1978;3:637-650.
60. Norman AW, Henry H. 1,25-dihydroxycholecalciferol - a hormonally active form of vitamin D3. Rec Prog Horm Res 1974;30:431-430. 61. Sos J. An investigation into nutritional factors of experimental cardiopathy. In Bajusz E & Rona G, eds.Electrolytes and Cardiovascular Disease: Fundamental Aspects. Baltimore: Williams & Wilkins, 1965:161-180.
62. Selye H. The Pluricausal Cardiomyopathies. Springfield IL: Charles C Thomas, 1961.
63. Karppanen H. Epidemiologic studies on the relationship between magnesium intake and cardiovascular diseases. Artery 1981;9: 190-199.
64. Kalbfleisch JM, Lindeman RD, Ginn HE, Smith WO. Effects of ethanol administration on urinary excretion of magnesium and other electrolytes in alcoholic and normal subjects. J Clin Invest 1963;42:1471-1475.
65. McCollister RJ, Prasad AS, Doe RP, Flink EB. Normal renal magnesium clearance and the effect of water loading, chlorthiazide and ethanol on magnesium clearance. J Lab Clin Med 1958;52:928.
66. McCollister RJ, Flink EB, Lewis MD. Urinary excretion of magnesium in man following the ingestion of alcohol. Am J Clin Nutr 1963;12:415-420.
67. Flink EB, Stutzman FL, Anderson AR, Konig T, Fraser R: Magnesium deficiency after prolonged parenteral fluid administration and after chronic alcoholism complicated by delirium tremens. J Lab Clin Med 1954;43:956-968.
68. Flink EB: Magnesium deficiency in alcoholism. Clin Exp Res 1986; 10:590-594, .
69. Horton R, Biglieri EG. Effect of aldosterone on the metabolism of magnesium. J Clin Endocrin Metab 1962;22:1187-1192.
70. Flink EB, Shane SR, Scobbo RR, Blehschmidt NG, McDowell P. Relationship of free fatty acids and magnesium in ethanol withdrawal in Dogs. Metabolism 1979;28:858-865.
71. Zieve L. Influence of magnesium deficiency on the utilization of thiamine. Ann NY Acad Sci 1969;162:732-743.
72. Itokawa Y, Tseng L-F, Fujiwara M. Thiamine metabolism in magnesium-deficient rats. J Nutr Sc Vit 1974;20:249-255.
73. Itokawa Y, Inoue K, Natori Y, Okazaki K, Fujiwara M. Effect of thiamine on growth, tissue magnesium and thiamine levels and on transketolase in magnesium deficient rats. J Vitaminol 1972;18: 159-164.
74. Seelig MS. Nutritional status and requirements of magnesium. Magnesium Bull 1986;8:170-185.
75. Hoffstrom KA: Phosphor, Calcium and Magnesium. Skand Arch Physiol 1916;23:326-420.
76. Franz KB: Magnesium intake during pregnancy. Magnesium 1985;6: 18-27.
77. Endres JM, Sawicki M, Casper JA. Dietary assessment of pregnant women in a supplemental food program. J Am Diet Assoc 1981;79: 121-126.
78. Ashe JR, Schofield FA, Gram MR. The retention of calcium, phosphorus and magnesium during pregnancy: the adequacy of prenatal diets with and without supplementation. Am J Clin Nutr 1979;32:286-291.
79. Johnson NE, Phillips CA: Magnesium contents of pregnant women. In Cantin M, Seelig MS, eds. Magnesium in Health & Disease, New York: SP Med & Sci Books 1980: 827-831.
80. Seelig MS: Possible roles of magnesium in disorders of the aged. In Regelson W, Sinex FM, eds. Intervention in the Aging Process, Part A: Quantitation, Epidemiology, Clinical Research. New York: AR Liss, Inc, 1983:279-205.
81. Johansson G. Magnesium metabolism. Studies in health, primary hyperparathyroidism and renal stone disease. Scand J Urol Nephrol 1979;51:1-47.
82. Mountakalakis TD. Effects of aging, chronic disease, and multiple supplements on magnesium requirements. Magnesium 1987:6:5-11.
83. Vir SC, Love AHG. Nutritional status of institutionalized and non-institutionalized Aged in Belfast. Am J Clin Nutr 1979;32: 1934-1947.
84. Fehlinger R, Fauk D, Seidel K. Hypomagnesemia and transient ischemic cerebral attacks. Magnesium Bull 1984;6:100-104.
85. Heroux O, Peter D, Heggtveit A. Long-term effect of subnormal magnesium on magnesium and calcium contents of organs, on cold tolerance and on lifespan and its pathological consequences in rats. J Nutr 1977;107:1640-1652.
86. Cantin M. Relationship of juxtaglomerular apparatus and adrenal cortex to biochemical and extracellular fluid volume changes in magnesium deficiency. Lab Investig 1970;22:558-568.
87. Mader IJ, Iseri LT. Spontaneous hypopotassemia, hypomagnesemia, alkalosis and tetany due to hypersecretion of corticosterone- like mineralocorticoid. Am J Med 1955;19:976-988.
88. Douglas WW, Rubin RP. The Effects of alkaline earths and other divalent cations on adrenal medullary secretion. J Physiol 1964;175:231-241.
89. Boullin D.J. The action of extracellular cations on the release of the sympathetic transmitter from peripheral nerves. J Physiol 1967;89:85-99.
90. Ising H. Interaction of noise-induced stress and Mg decrease. Artery 1981;9:205-211.
91. Ising H, Bertschat F, Ibe K, Stoboy V, Goossen C, Hengst G. Stress-induced Ca/Mg shifts and vascular response in animals and men; comparison to electrolyte alterations in myocardial infarction patients. Magnesium Bull 1986;8:95-103.
92. Ebel H, Guenther T: Role of magnesium in cardiac disease. J Clin Chem Clin Biochem 1983; 21:249-256.
93. Lehr D, Krukowski M, Colon R. Correlation of myocardial and renal necrosis with tissue electrolyte changes. JAMA 1966; 197:105-112.
94. Kraikitpanitch S, Haygood CC, Baxter DJ, Yunice AA, Lindeman RD. Effects of acetylsalicylic acid, dipyridamole, and hydrocortisone on epinephrine-induced myocardial injury in dogs. Am Heart J 1976;92:615-622.
95. Lehr D. Magnesium and cardiac necrosis. Magnesium Bull 1981; 3(1A):178-191.
96. Abraham AS, Baron E, Eylath U. Changes in the magnesium content of tissues following myocardial damage in rats. Med Biol 1981;59: 99-102.
97. Fleckenstein A, Janke J, Doering HJ, Pachinger O. Myocardial fiber necrosis due to intracellular Ca overload - a new principle in cardiac pathophysiology. Rec Adv Stud Card Struct Metabol 1972;4:563-580.
98. Spah F, Fleckenstein A. Evidence of a new preferentially Mg- carrying transport system besides the fast Na and the slow Ca channels in the excited myocardial sarcolemma membrane. J Mol Cell Cardiol 1979;11:1109-1129.
99. Maguire ME, Erdos JJ. Magnesium but not calcium accumulation is inhibited by B-adrenergic stimulation in S49 lymphoma cells. J Biol Chem 1978;253:6633-6635.
100. Rayssiguier Y. Hypomagnesemia resulting from adrenalin infusion in ewes: its relation to lipolysis. Horm Metab Res 1977;9:309-314.
101. Flink EB, Brick JE, Shane SR: Alterations of long-chain free fatty acid and magnesium concentrations in acute myocardial infarction. Arch Intern Med 1981;141:441-443.
102. Elliott DA, Rizak MA. Epinephrine and adrenocorticotropic hormone-stimulated magnesium accumulation in adipocytes and their plasma membranes. J Biol Chem 1973;249:3985-3990.
103. Vormann J, Foerster R, Guenther T, Ebel H. Lipolysis-induced Mg uptake into fat cells. Magnesium Bull 1983;5:39-41.
104. Altura BT. Type A behavior and coronary vasospasm: a possible role of hypomagnesemia. Med Hypoth 1980;6:753-757.
105. Henrotte JG. Type A behavior and magnesium metabolism. Magnesium
106. Simon J, Kruzej E, Svarc V, Krizk M. Correlation of A B behavior pattern, alcohol intake, HDL-cholesterol and serum magnesium levels in middle-aged men. Act Nerv Super 1983;25:105-107.
107. Henrotte JG, Plouin PF, Levy-Leboyer G, Moser G, Sideroff- Girault N, Franck G, Santarromana M, Pineau M. Blood and urinary magnesium, zinc, calcium, free fatty acids and catecholamines in type A and type B subjects. J Am Coll Nutr 1985;4:165-172.
108. Durlach J (Transl by D Wilson). Magnesium in Clinical Practice. London: J Libbey & Co, 1988.
109. Classen H-G, Classen O, Fischer G, Fischer H, Helbig J, Rummler HG, Schimatschek H. Magnesium: Prevention of stress-induced cardiovascular damage. Magnesium Bull 1986;8:140-144.
110. Ducroux T: L'Enfant spasmophile. Aspects diagnostiques et therapeutiques. Magnesium Bull 1984;6:9-16.
111. Heggtveit HA. The cardiomyopathy of Mg-deficiency. In Bajusz E, ed. Electrolytes and Cardiovascular Diseases, Vol 1. New York: S Karger, 1965:204-220.
112. Heggtveit HA, Tanser L, Mishra RK. Cardiac necrosis and calcification in experimental magnesium deficiency. Am J Path 1964;45:757-782.
113. Sordahl LA. Effects of magnesium, ruthenium red, and the antibiotic ionophore A-23187 on initial rates of calcium uptake and release by heart mitochondria. Arch Biochem Biophys 1974;167:103-115.
114. Sordahl LA, Silver BB. Pathological accumulation of calcium by mitochondria: modulation by magnesium. Rec Adv Structure & Metabolism 1975;6:85-93.
115. Janke J, Fleckenstein A, Hein B, Leder O, Sigel H. Prevention of myocardial Ca overload and necrotization by Mg and K salts or acidosis. Rec Adv Stud Card Struct Metab 1975;6:33-42.
116. Lehr D, Chau R, Irene S. Possible role of magnesium loss in the pathogenesis of myocardial fiber necrosis. Rec Adv Stud Card Struct Metab 1975;6:258-273.
117. Heggtveit HA. Contribution of electron microscopy to the study of myocardial ischemia. WHO 1971;41:865-872.
118. Altura BM, Altura BT. New perspectives on the role of magnesium in the pathophysiology of the cardiovascular system, I. Clinical aspects. Magnesium 1985;4:226-244.
119. Altura BM, Altura BT. New perspectives on the role of magnesium in the pathophysiology of the cardiovascular system. II. Experimental aspects. Magnesium 1985;245-271.
120. Bloom S. Coronary arterial lesions in Mg-deficient hamsters. Magnesium 1985:4:82-95.
121. Duguid JB. Thrombosis as a factor in the pathogenesis of coronary atherosclerosis. J Pathol Bacteriol 1946;58:207-212.
122. Stevenson MM, Yoder I. Studies of platelet aggregation, plasma adenosine diphosphate breakdown, and blood coagulation in magnesium deficient calves and rats. Thromb Diath Hemorrh 1972; 23:299-305.
123. Adams JH, Mitchell JRA: The effect of agents which modify platelet behavior and of magnesium ions on thrombus formation in vivo. Thrombos Haemostas 1979;42:603-610.
124. Gertz SD, Wajnberg RS, Kurgan A, Uretzky G. Effect of magnesium sulfate on thrombus formation following partial arterial constriction: implications for coronary vasospasm. Magnesium 1987;6:225-235.
125. Durlach J. Magnesium deficiency thrombosis (letter). Lancet 1967;1:1967.
126. Durlach J. Pilule, et thrombose (des plaquettes, des estrogens et du magnesium). Rev Fr Endocrinol Clin 1970;11:45-54.
127. Hughes A Tonks RS. Platelets, magnesium and myocardial infarction. Lancet 1965;1:1044-1046.
128. Cohen L, Kitzes R. Prompt termination and/or prevention of coldpressor-stimulation-induced vasoconstriction of different beds by magnesium sulfate in patients with Prinzmetal's angina. Magnesium 1986;5:144-149.
129. Roberts WC, Buja LM. The frequency and significance of coronary arterial thrombi and other observations in fatal acute myocardial infarction. Am J Med 1972;52:425-443.
130. Hudson REB. The cardiomyopathies: order from chaos. Am J Cardiol 1970;25:70-77.
131. Altura BM, Ischemic heartdisease and magnesium. Magnesium 1988; 7:57-67.
132. Ross R, Glomsett JA. The pathogenesis of atherosclerosis. N Engl L Med 1976;195:420-425.
133. Borchgrevink PC, Oksendal AN, Jynge P. Acute extracellular magnesium deficiency and myocardial tolerance to ischemia. J Am Coll Nutr 1987;6:125-130.
134. Chang C, Varghese PJ, Downey J, Bloom S. Magnesium deficiency and myocardial infarct size in the dog. J Am Coll Cardiol 1985;5: 280-289.
135. Hearse DJ, Stewart DA, Braimbridge MVL. Myocardial protection during ischemic cardiac arrest. The importance of magnesium in cardioplegic infusates. J Thor Cardiavasc Surg 1978;75:877-885.
136. Shattock MJ, Hearse DJ, Fry CH: The ionic basis of the anti- ischemic and anti-arrhythmic properties of magnesium in the heart. J Am Coll Nutr 1987;6:27-33.
137. Mansford KRL, Hearse DJ. Metabolic approaches to myocardial infarction. In Hems DA, ed.Biologically Active Substances: Exploration and Exploitation. Chichester: John Wiley & Sons, 1977:239-264.
138. Greenberg D, Tufts E. The nature of magnesium tetany. Am J Physiol 1938;121:416-423.
139. Syllm-Rapoport I, Strassburger I, Gruneberg D, Zirbel C. Electrocardiographic studies in dogs with experimental magnesium deficiency. J Paediat 1962; 60:801-804.
140. Wener J, Pintar K, Simon MA, Motola R, Friedman R, Mayman A, Schucher R. The effects of prolonged hypomagnesemia on the cardiovascular system in young dogs. Am Heart J 1964;67:221-231.
141. Vitale JJ, Hellerstein EE, Nakamura M, Lown B. Effects of magnesium-deficient diet upon puppies. Circ Res 1961;9:387-394.
142. Seelig MS. Electrocardiographic patterns of magnesium depletion appearing in alcoholic heart disease. Ann NY Acad Sci 1969; 162:906-917.
143. Burch GE, Giles TD. The importance of magnesium deficiency in cardiovascular disease. Am Heart J 1977;4:649-657.
144. Sheehan JP, Seelig MS. Interactions of magnesium and potassium in the pathogenesis of cardiovascular disease. Magnesium 1984;301- 314.
145. Rude RK, Oldham SB, Sharp CF, Singer FR. Parathyroid hormone secretion in magnesium deficiency. J Clin Endocrinol Metab 1978; 47:800-806.
146. Iseri LT, French JH. Magnesium: nature's physiologic calcium blocker. Am Heart J 1984;108:188-193.
147. Dyckner TH, Wester PO. Magnesium-electrophysiological effects. Magnesium Bull 1986;8:219-222.
148. Kulick DL, Hong R, Ryzen E, Rude RK, Rubin JN, Elkayam U, Rahimtoola SH, Bhandari AK. Electrophysiologic effects of intravenous magnesium in patients with normal conduction systems and no clinical evidence of significant cardiac disease. Am Heart J 1988;115:367-373.
149. Abraham AS, Rosenman D, Meshulam Z, Zion M, Eylath U. Serum, lymphocyte, and erythrocyte potassium, magnesium, and calcium concentrations and their relation to tachyarrhythmias in patients with acute myocardial infarction. Am J Med 1986;81:983-988.
150. Ising H, Guenther T, Bertschat F, Ibe K, Stoboy V, Heldman E. Alterations of electrolytes in serum and erythrocytes after myocardial infarction. Magnesium 1987;6:192-200.
151. Abraham AS. Potassium and magnesium status in ischaemic heart disease. Magn Res 1988;1: 53-57.
152. Rasmussen HS, McNair P, Goransson L, Balslov S, Larsen OG, Aurup P. Magnesium deficiency in patients with ischemic heart disease with and without acute myocardial infarction uncovered by an intravenous loading test. Arch Intern Med 1988;148:329-332.
153. Ryzen E, Elkayam U, Rude RK. Low blood mononuclear cell magnesium in intensive cardiac care unit patients. Am Heart J 1986;111: 475-480.
154. Randall RE Jr, Rossmeisl EC, Bleifer KH. Magnesium depletion in man. Ann Intern Med 1959;50:257-287.
155. Brigden W, Robinson J. Alcoholic heart disease. Br Med J 1964; 2:1283-1289.
156. Fankushen D, Raskin D, Dimich A, Wallach S. The significance of hypomagnesemia in alcoholic patients. Am J Med 1964;37:802-812.
157. Loeb HS, Raymond P, Gunnar RM, Tobin JR. Paroxysmal ventricular fibrillation in two patients with hypomagnesemia. Treatment by transvenous pacing. Circulation 1968;37:210-215.
158. Ricketts HH, Denison EK, Haywood IJ. Unusual T-wave abnormality. Repolarization alternans associated with hypomagnesemia, acute alcoholism and cardiomyopathy. JAMA 1969;207:365-366.
159. Luomanmaki K, Heikkila J, Hartikainen M. T-wave alternans associated with heart failure and hypomagnesemia in alcoholic cardiomyopathy. Europ J Cardiol 1975;3:167-170.
160. Kellaway G, Ewen K. Magnesium deficiency complicating prolonged gastric suction. New Zeal Med J 1962;61:137-142.
161. Thoren L. Magnesium deficiency in gastrointestinal fluid loss. Acta Chir Scand 1963;Suppl 306:1-65.
162. Levine SR, Crowley TJ, Hai HA. Hypomagnesemia and ventricular tachycardia. Chest 1982;81:244-247.
163. Lim P, Jacob E. Tissue magnesium level in chronic diarrhea. J Lab Clin Med 1972;80:313-321.
164. Caddell JL. The effect of magnesium therapy on cardiovascular and electrocardiographic changes in severe protein-calorie malnutrition. Trop Geogr Med 1969;21:33-38.
165. Dooling ED, Stern L. Hypomagnesemia with convulsions in a newborn infant. Report of a case associated with maternal hypophosphatemia. Can Med Assc J 1967;97:827-831.
166. Bajpai PC, Hasan M, Gupta AK, Kunwar KB. Electrocardiographic changes in hypomagnesemia. Indian Heart J 1972;24:271-276.
167. Killen DA, Grogan EL II, Gower IE, Collins IS, Collins HA. Effect of ACD blood prime on plasma calcium and magnesium. Ann Thorac Surg 1972;18:371-380.
168. Scheinman MM, Sullivan RW, Hyatt KH. Magnesium metabolism in patients undergoing cardiopulmonary bypass. Circulation 1969;39- 40(Suppl I);40:1235-1241.
169. Holden MP, Ionescu MI, Wooler GH. Magnesium in patients undergoing open-heart surgery. Thorax 1972;27:212-218.
170. Holden MP. The value of magnesium supplements during open-heart surgery. A double-blind trial. In Naito KH, ed. Nutrition and Heart Disease. SP Press 1982:273-283.
171. Khan RMA, Hodge JS, Bassett HFM. Magnesium in open-heart surgery. J Thorac Cardiovasc Surg 1973;66:185-191.
172. Hearse DJ, Stewart DA, Braimbridge MV. Cellular protection during myocardial ischemia. The development and characterization of a procedure for the induction of reversible ischemic arrest. Circulation 1976;54:193-202.
173. Morton BC, Smith FM, McKibbon TJ, Nair RC, Poznanski WJ. Magnesium therapy in acute myocardial infarction. Magnesium Bull 1981;3(1A):192-194.
174. Morton BC, Smith FM, Nair RC, McKibbon TG, Poznanski WJ. The clinical effects of magnesium sulphate treatment in acute myocardial infarction. Magnesium Bull 1984;4:133-136.
175. Rasmussen HS, McNair P, Norregard P, Backer V, Lindeneg O, Balslev S. Intravenous magnesium in acute myocardial infarction. Lancet 1986:234-236.
176. Abraham AS, Rosenman D, Kramer M, Balkin J, Zion MM, Farbstein H, Eylath U. Magnesium in the prevention of lethal arrhythmias in acute myocardial infarction. Arch Intern Med 1987;147:753-755.
177. Rasmussen HS. Justification for intravenous magnesium therapy in acute myocardial infarction. Magn Res 1988;1:59-73.
178. Dyckner T. Serum magnesium in acute myocardial infarction. Acta med scand 1980;207:59-66.
179. Packer M. Sudden unexpected death in patients with congestive heart failure: a second frontier. Circulation 1985;72:681-685.
180. Wester PO, Dyckner T. Intracellular electrolytes in cardiac failure. Acta Med Scand 1986;707Suppl:33-36.
181. Wester PO, Dyckner T. Magnesium in cardiac failure and diuretic treatment. Magnesium Bull 1986;8:204-209.
182. Packer M, Gottlieb SS, Blum MA. Immediate and long-term pathophysiologic mechanisms underlying the genesis of sudden cardiac death in patients with congestive heart failure. Am J Med 1987;82 (Suppl 3A):4-10, 1987.
183. Francis GS. Neurohumoral mechanisms involved in congestive heart failure. Am J Cardiol 1985;55:15A-21A.
184. Dyckner T, Wester PO: Ventricular extrasystoles and intracellular electrolytes before and after potassium and magnesium infusions in patients on diuretic treatment. Am Heart J 1979;97:12-18.
185. Luccioni R, Frances Y, Kiegel P, Collet F. Prolapsus valvulaire mitral - spasmophilie et deficit magnesien. Magnesium Bull 1982;4:62-67.
186. Galland LD, Baker SM, McLellan RK. Magnesium deficiency in the pathogenesis of mitral valve prolapse. Magnesium 1986;5:165-174.
187. Henrotte JG. The variability of human red blood cell magnesium level according to HLA groups. Tissue-Antigens 1980;15:419-430.
188. Braun WE, Ronan JA, Schachter B, Gardin J, Isner J, Greek D. HLA antigens in mitral valve prolapse. Transplant Proc 1977;9:1869- 1871.
189. Kaplan NM: Dietary aspects of the treatment of hypertension. Ann Rev Public Health 1986;7:503-519.
190. McCarron DA, Morris CD, Cole C. Dietary calcium in human hypertension. Science 1982;267-269, .
191. Kaplan NM, Meese RB. The calcium deficiency hypothesis of hypertension: a critique. Ann Intern Med 1986;105:947-955.
192. Haddy FJ, Seelig MS. Magnesium and the Arteries. II. Physiologic effects of electrolyte abnormalities on arterial resistance. In Cantin M, Seelig MS, eds. Magnesium in Health and Disease. New York: SP Med & Sc Books, 1980:639-657.
193. Altura BM. Altura BT. Interactions of Mg and K on blood vessels - aspects in view of hypertension. Review of present status and new findings. Magnesium 1984;3:175-194.
194. Altura BM, Altura BT. Role of magnesium ions in contractility of blood vessels ans skeletal muscles. Magn Bulletin 1981;3:102-114.
195. Seelig MS, Berger AR, Avioli LA. Speculations on renal hormonal, and metabolic aberrations in a patient with marginal magnesium deficiency. In Cantin M, MS Seelig, eds. Magnesium in Health and Disease. New York: SP Med & Sc Books, 1980:459-468.
196. Resnick LM, Laragh JH, Sealy JE, Alderman MH. Divalent cations in essential hypertension. New Engl J Med 1983;309:888-891.
197. Resnick LM, Gupta RK, Laragh JH. Intracellular free magnesium in erythrocytes of essential hypertension: relation to blood pressure and serum divalent cations. Proc Natk Acad Sci USA 1984;81:6511-6515.
198. Resnick LM. Uniformity and diversity of calcium metabolism in hypertension. A conceptual framework. Am J Med 1987;82(suppl 1B): 16-26.
199. Dyckner T, Wester PO. Effects of magnesium infusions in diuretic induced hyponatremia. Lancet 1981;1:585-586.
200. Dyckner T, Wester PO. Effect of magnesium on blood pressure. Br Med J 1983;286:1847-1849.
201. Zwillinger L. On magnesium's effect on the heart. Klin Wochenschr 1935;14:1429-1433. (in German)
202. Kim YW, Andrews CE, Ruth WE. Serum magnesium and cardiac arrhythmias with special reference to digitalis intoxication. Am J Med Sci 1961;242:87-92.
203. Beller GA, Hood WB Jr, Smith TW, Abelmann WH, Wacker WEC. Correlation of serum magnesium levels and cardiac digitalis intoxication. Am J Cardiol 1974;33:225-229.
204. Iseri LT. Potassium, magnesium, and digitalis toxicity. In Whang R, ed. Potassium: Its Biologic Significance . Boca Raton FLa: CRC Press, 1983:125-135 .
205. Cohen L, Kitzes R. Magnesium sulfate and digitalis toxic arrhythmias. JAMA 1983;249:2808-2810.
206. Whang R, Oei TO, Watanabe A. Frequency of hypomagnesemia in hospitalized patients receiving digitalis. Arch Intern Med 1985; 145:655-656.
207. DeCarli C, Sprouse G, LaRosa JC. Serum magnesium levels in symptomatic atrial fibrillation and their relation to rhythm control by intravenous digoxin. Am J Cardiol 1986;57:956-959.
208. Kass RS, Lederer WJ, Tsien RW, Weingart R. Role of calcium ions in transient inward current and after contraction induced by strophanthidin in cardiac Purkinje fibers. J Physiol (London) 1978;281:187-208.
209. Specter MJ, Schweizer E, Goldman RH. Studies on magnesium's mechanism of action in digitalis induced arrhythmias. Circulation 1975;52:1001-1005.
210. Ghani MF, Smith JR. The effectiveness of magnesium chloride in the treatment of ventricular tachyarrhythmias due to digitalis intoxication. Am Heart J 1974;88:621-626.
211. MacIntyre I, Hanna S, Booth CC, Read AE. Intracellular magnesium deficiency in man. Clin Sci 1961;20:297-305.
212. Lim P, Jacob E, Dong S, Khoo OT. Values for tissue magnesium as a guide for detecting magnesium deficiency. J Clin Path 1969; 22:417-421.
213. Merrill JP, Hampers CL. Uremia (Med Progr Series). N Engl J Med 1970;282:1014-1021.
214. Sheehan J, White A. Diuretic-associated hypomagnaesemia. Br Med J 1982;285:1157-1159.
215. Martin BJ, Milligan K: Diuretic-associated hypomagnesemia in the elderly. Arch Intern Med 1987;1768-1771.
216. Hollifield JW. Magnesium depletion, diuretics, and arrhythmias. Am J Med 1987;82 (Suppl 3A):30-37.
217. Multiple Risk Factor Intervention Trial Research Group. Multiple risk factor intervention trial: risk factor changes and mortality results. JAMA 1982;248:2465-2477.
218. Sherwin R. Sudden death in men with increased risk of myocardial infarction - the MRFIT Program. Drugs 1984;28 (Suppl 1):46-53.
219. Whelton PK. Diuretics and arrhythmias in the Medical Research Council Trial. Drugs 1984;28 (Suppl 1):54-65.
220. Morgan TO, Adams WR, Hodgson M, Gibberd RW. Failure of therapy to improve the prognosis in elderly males with hypertension. Med J Aust 2: 27-31, 1980.
221. Amery A, Birkhager W, Brixko P.: Mortality and morbidity results from the European Working Party on high blood pressure in the elderly. Lancet 1985;1:1249-1354.
222. Kuller L, Farrier N, Caggiula A, Borhani N, Dunkle S. Relationship of diuretic therapy and serum magnesium levels among participants in the Multiple Risk Facor Intervention Trial. Am J Epidemiol 1985;122:1045-1059.
223. Holliday MA, Lukenbill A, Hancock C. Acute metabolic alkalosis: its effect on potassium and acid excretion. J Clin Invest 1955; 34:428-433.
224. Atkins EL, Schwartz WB: Factors governing correction of the alkalosis associated with potassium deficiency; the critical role of chloride in the recovery process. J Clin Invest 1962;41: 218-229.
225. Kassirer JP, Berkman PM, Lawrenz DR, Schwartz WB. The critical role of chloride in the correction of hypokalemic alkalosis in man. Am J Med 1965;38:172-190.
226. Iseri LT, Fairshter RD, Hardemann JL, Brodsky MA. Magnesium and potassium therapy in multifocal atrial tachycardia. Am Heart J 1985;110:789-794.
227. Whang R, Wagner R. The influence of venous occlusion and exercise on serum magnesium concentration. Metabolism 1966;15:608-612.
228. Engel RR, Elin RJ. Hypermagnesemia from birth asphyxia. J Pediat 1970;77:631-637.
229. Brater DC, Morrelli HF. Systemic alkalosis and digitalis related arrhythmias. Acta Med Scand 1981;647:79-85.
230. Urakabe S, Nakata K, Ando A, Orita Y, Abe H. Hypokalemia and metabolic alkalosis resulting from overuse of magnesium oxide. Jpn Circ J 1975;39:1135-113.
231. Schimatschek HT, Classen HG, Thoni H, Haubold W. Acid-base changes in rats kept on highly magnesium enriched diets using different magnesium compounds. Magn Bulletin 1987;9:161-176. (in German)
232. Classen H-G, Marquardt P, Spaeth M, Ebel H, Schumacher K-A. Improvement by chlorine of the intestinal absorption of inorganic and organic Mg-compounds and their protective effect against adrenergic cardiopathy. Rec Adv Stud Card Struct Metab 1975;111-119.
233. Classen H-G. Magnesium and potassium deprivation and supplementation in animals and man: aspects in view of intestinal absorption. Magnesium 1984;2:257-264.
234. Classen H-G, Fischer G, Jacob R, Marx J,Schimatschek H, Stein C. Prenecrotic electrolyte alterations of the adrenergic cardiopathy: potentiation by magnesium depletion and prevention by high dietary magnesium levels and verapamil. Magnesium Bulletin 1986;8: 82-92.
235. Bajusz E. Age factor and myocardial necrosis: experimental studies on the sensitizing effect of K-, Mg-, and Cl- deficiencies. Gerontologia 1963;8:66-80.
236. Davis WH, Ziady F. The effect of oral magnesium chloride therapy on the QTc and QTu intervals of the electrocardiogram. S Afr Med J 1978;53:591-593.
237. Reyes AJ, Leary WP, Acosta-Barrios TN, Davis WH. Magnesium supplementation in hypertension treated with hydrochlorthiazide. Curr Ther Res 36:332-340, 1984.
238. Ford ES, Mokdad AH. Dietary magnesium intake in a national sample of US adults. J Nutr 2003;133:2879–82.
239. Altura BT, Brust M, Bloom S, Barbour RL, Stempak JG, Altura BM. Magnesium dietary intake modulates blood lipid levels and atherogenesis. Proc Natl Acad Sci USA 1990;87:1840–4.1.
240. Orimo H, Ouchi Y. The role of calcium and magnesium in the development of atherosclerosis: experimental and clinical evidence. Ann N Y Acad Sci 1990;598:444–57.
241. Song Y, Ford ES, Manson JE, Liu S. Relations of magnesium intake with metabolic risk factors and risks of type 2 diabetes, hypertension, and cardiovascular disease: a critical appraisal. Curr Nutr Food Sci 2005;3:231–43.
242. Chakraborti S, Chakraborti T, Mandal M, Mandal A, Das S, Ghosh S. Protective role of magnesium in cardiovascular diseases: a review. Mol Cell Biochem 2002;238:163–79.
243. Larsson SC, Orsini N, Wolk A. Dietary magnesium intake and risk of stroke: a meta-analysis of prospective studies. Am J Clin Nutr 2012; 95:362–6.
244. Zwillinger L. Uber die Magnesiumwirkung auf das HerZ. Klin Wochenschr 1935;14:1429 (in German).
245. Kobayashi J. [Geographical relationship between the chemical nature of river water and death-rate from apoplexy.] Berichte d Ohara Inst f landwirtsch Biologie 1957;11:12–21 (in German).
246. Schwartz S. The fallacy of the ecological fallacy: the potential misuse of a concept and the consequences. Am J Public Health 1994;84:819–24. 10. Song Y, Manson JE, Cook NR, Albert CM, Buring JE, Liu S. Dietary magnesium intake and risk of cardiovascular disease among women. Am J Cardiol 2005;96:1135–41.
247. Ohira T, Peacock JM, Iso H, Chambless LE, Rosamond WD, Folsom AR. Serum and dietary magnesium and risk of ischemic stroke: the Atherosclerosis Risk in Communities Study. Am J Epidemiol 2009; 169:1437–44.
248. Reinhart RA. Magnesium metabolism: a review with special reference to the relationship between intracellular content and serum levels. Arch Intern Med 1988;148:2415–20.
249. Izumi Y, Roussel S, Pinard E, Seylaz J. Reduction of infarct volume by magnesium after middle cerebral artery occlusion in rats. J Cereb Blood Flow Metab 1991;11:1025–30.
250. Marinov MB, Harbaugh KS, Hoopes PJ, Pikus HJ, Harbaugh RE. Neuroprotective effects of preischemia intraarterial magnesium sulfate in reversible focal cerebral ischemia. J Neurosurg 1996;85:117–24.
251. Yang Y, Li Q, Ahmad F, Shuaib A. Survival and histological evaluation of therapeutic window of post-ischemia treatment with magnesium sulfate in embolic stroke model of rat. Neurosci Lett 2000;285:119–22.
252. Nowak L, Bregestovski P, Ascher P, Herbet A, Prochiantz A. Magnesium gates glutamate-activated channels in mouse central neurones. Nature 1984;307:462–5.
253. Muir KW, Lees KR, Ford I, Davis S. Magnesium for acute stroke (Intravenous Magnesium Efficacy in Stroke trial): randomised controlled trial. Lancet 2004;363:439–45.
254. Song Y, Hsu YH, Niu T, Manson JE, Buring JE, Liu S. Common genetic variants of the ion channel transient receptor potential membrane melastatin 6 and 7 (TRPM6 and TRPM7), magnesium intake, and risk of type 2 diabetes in women. BMC Med Genet 2009;10:4.
255. Chacko SA, Sul J, Song Y, Li X, LeBlanc J, You Y, Butch A, Liu S. Magnesium supplementation, metabolic and inflammatory markers, and global genomic and proteomic profiling: a randomized, double-blind, controlled, crossover trial in overweight individuals. Am J Clin Nutr 2011;93:463–73.